| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/30/2002 | WO2002042435A2 Regulation of human tyrosine phosphatase |
| 05/30/2002 | WO2002042429A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | WO2002042424A2 Seed-preferred regulatory elements and uses thereof |
| 05/30/2002 | WO2002042418A2 3-hydroxypropionic acid and other organic compounds |
| 05/30/2002 | WO2002042325A2 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | WO2002042320A2 Haplotypes of the gsr gene |
| 05/30/2002 | WO2002020799A3 Nucleotide sequences which code for the luxs gene |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002020542A3 Nucleotide sequences which code for the gap2 gene |
| 05/30/2002 | WO2002018618A3 PROCESS FOR THE PREPARATION OF A β-LACTAM NUCLEUS AND THE APPLICATION THEREOF |
| 05/30/2002 | WO2002006319A3 Nucleic acid molecule which codes for a plant amp deaminase |
| 05/30/2002 | WO2002002756A3 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 05/30/2002 | WO2001098482A3 Liver-specific gene expression cassettes, and methods of use |
| 05/30/2002 | WO2001096577A8 Production of secreted polypeptides |
| 05/30/2002 | WO2001094606A3 Method for producing c9 aldehydes, c9 alcohols and esters thereof |
| 05/30/2002 | WO2001094598A3 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
| 05/30/2002 | WO2001094562A3 Cold sensitive mutant dna polymerases |
| 05/30/2002 | WO2001094561A3 The non-mevalonate isoprenoid pathway |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001079512A3 Vector and method for targeted replacement and disruption of an integrated dna sequence |
| 05/30/2002 | WO2001075121A9 16836, a human phospholipase c family member and uses thereof |
| 05/30/2002 | WO2001075119A3 21509 and 33770, novel human dehydrogenase family members and uses thereof |
| 05/30/2002 | WO2001071014A3 Expression of recombinant human acetylcholinesterase in transgenic plants |
| 05/30/2002 | WO2001066760A3 Novel human kinase interacting protein and polynucleotides encoding the same |
| 05/30/2002 | WO2001055434A8 Inhibition of carbohydrate-modifying enzymes in host organisms |
| 05/30/2002 | WO2001053473A3 Methods for amplifying genetic material and uses thereof |
| 05/30/2002 | WO2001053456A3 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 05/30/2002 | WO2001048179A9 Binding of polyamides to proteins having sh3 or ww domains |
| 05/30/2002 | WO2001045494A9 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/30/2002 | WO2001042509A9 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 05/30/2002 | WO2001042455A9 Directed evolution of biosynthetic and biodegration pathways |
| 05/30/2002 | WO2001038511A8 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/30/2002 | WO2001037194A9 Crystallizable compositions comprising a caspase-7 |
| 05/30/2002 | WO2001030998A9 Production of functional hybrid genes and proteins |
| 05/30/2002 | WO2001016300A3 Method of identifying inhibitors of cdc25 |
| 05/30/2002 | WO2000075366A3 Transcription-based gene mapping |
| 05/30/2002 | WO2000052205A8 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 05/30/2002 | US20020066124 GTP binding stress-related proteins and methods of use in plants |
| 05/30/2002 | US20020066123 Transgenic plants; disease resistance |
| 05/30/2002 | US20020065418 Viral polymerase inhibitors |
| 05/30/2002 | US20020065408 Generating heterologous proteins in eukaryotic cells; obtain cell, transform, express vector, recover heterologous protein |
| 05/30/2002 | US20020065406 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of hematopoietic defects |
| 05/30/2002 | US20020065404 Cytidine monophosphate-sialic acid transporter, and hexosaminidase polynucleotides and polypeptides, and uses based thereon. |
| 05/30/2002 | US20020065403 New nucleotide sequences which code for pck gene |
| 05/30/2002 | US20020065397 Protecting therapeutic compositions from host-mediated inactivation |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065300 Administering to a mammal a pigmentation-changing effective amount of a Bowman-Birk Inhibitor or of natural extract containing a Bowman-Birk Inhibitor |
| 05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
| 05/30/2002 | US20020065221 Control of protein synthesis, and screening method for agents |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064858 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 05/30/2002 | US20020064857 Non-selfdegrading endoprotease |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064854 Enzymatic polypeptide for use in detergents for automatic dishwashers and laundry detergents |
| 05/30/2002 | US20020064853 Nucleotide sequences coding enzymatic polypeptide for use in treatment of cancer, nervous system, cardiovascular and inflammatory disorders, restenosis and arteriosclerosis |
| 05/30/2002 | US20020064852 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of bone, reproductive, inflammatory, eating and nervous system disorders, infections, osteoarthritis, asthma, psoriasis, dermatitis, pain; injury; sepsis, cancers |
| 05/30/2002 | US20020064851 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
| 05/30/2002 | US20020064850 Nucleotide sequences for use in generating fructose polymers for food processing |
| 05/30/2002 | US20020064849 Human soluble testicular adenylyl cyclase |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064847 Polypeptide for use generation of preferential compounds |
| 05/30/2002 | US20020064845 Nuclelotide sequences coding enzymatic polypeptide for use in treatment of pain, inflamation, cancer, fever and osteoarthritis |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064840 Method for synthesizing an optically active cyanohydrin |
| 05/30/2002 | US20020064838 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 05/30/2002 | US20020064834 Microbiological production method for alpha-L-aspartyl-L-phenylalanine |
| 05/30/2002 | US20020064819 Polypeptide for use in the treatament and prevention of nervous system disorders |
| 05/30/2002 | US20020064816 Nuclelotide sequences coding polysaccharide metabolism protein for use in generating transgenic plants |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064783 Inhibition of bone tumor formation using antisense cDNA therapy |
| 05/30/2002 | US20020064771 Viral enzymatic polypeptide and associations for use in the prevention of viral diseases and infections |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | CA2430270A1 Methods and materials for the synthesis of organic products |
| 05/30/2002 | CA2429971A1 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
| 05/30/2002 | CA2429699A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | CA2429368A1 Production of stilbenes in transgenic plants and the method of producing thereof |
| 05/30/2002 | CA2429039A1 3-hydroxypropionic acid and other organic compounds |
| 05/30/2002 | CA2427661A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | CA2427340A1 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | CA2398924A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 05/29/2002 | EP1209237A2 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 05/29/2002 | EP1209236A1 phosphomevalonate kinases from plants |
| 05/29/2002 | EP1209235A1 Expression vector for fusion gene and method for producing immobilized enzyme |
| 05/29/2002 | EP1209234A1 Stereostructure of decarbamylase and method of using the same |
| 05/29/2002 | EP1209233A2 Alkaline proteases |
| 05/29/2002 | EP1209227A2 Cytochrome P450 hydroxylase, an important enzyme in brassinosteroid biosynthesis of plants |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1208848A1 Stable lactase compositions |
| 05/29/2002 | EP1208236A2 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks |
| 05/29/2002 | EP1208221A2 Screening for inhibitors of lumazine synthase |
| 05/29/2002 | EP1208216A2 Fatty acid desaturase gene from plants |
| 05/29/2002 | EP1208210A2 Archaeal replication accessory factors and methods of use |
| 05/29/2002 | EP1208209A1 Evolution and use of enzymes for combination and medicinal chemistry |
| 05/29/2002 | EP1208208A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 05/29/2002 | EP1208205A2 Methods for producing l-amino acids by increasing cellular nadph |
| 05/29/2002 | EP1208203A2 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
| 05/29/2002 | EP1208200A2 Transgenic animal model for neurodegenerative diseases |